Company News

SPH Phililab attend PharmChina in Shanghai China

SPH Phililab attended PharmChina in Shanghai China (May 12-13, booth # 72V07).  Mr. Qingchun Wang, our General Agent in China gave a roadshow presentation in the trade show.

SPH Phililab received a tentative approval

SPH Phililab  received a tentative approval letter from the FDA on Eslicarbazspine Tablets 200 mg, 400 mg, 600 mg and 800 mg (for SPH Shanghai Zhongxi Pharmaceutical Co. Ltd).

SPH Phililab received acceptance letters

SPH Phililab  received acceptance letters from the FDA on its ANDA submissions for Colesevelam Hydrochloride Tablet,625 mg and Colesevelam Hydrochloride for Oral Suspension, 3.75 g (for Shanghai Pharmaceuticals).

Agreement sign with SPH Shanghai Zhongxi Pharmaceutical Co. Ltd

SPH Phililab signed an agreement with SPH Shanghai Zhongxi Pharmaceutical Co. Ltd., for the development, FDA registration, and US marketing of a generic oral suspension product.

SPH Phililab Signing Ceremony

On August 7, 2018, the SPH Phililab Signing Ceremony was held in the Double Tree Hotel by Hilton at Plymouth Meeting, Pennsylvania. Delegates led by Cho Man, CEO and President of Shanghai Pharmaceutical Holding (SPH), attended the ceremony, marking the beginning of SPH Phililab, Inc, a joint venture between SPH and Phililab

Pharmula Laboratories signed an agreement with SPH

Pharmula Laboratories signed an agreement with SPH for the development, FDA registration, and US marketing of four generic drug products.

P4 Certification from FDA

Pharmula Laboratories received an acceptance letter and P4 Certification from FDA on its ANDA submission for Eslicarbazspine Tablets 200 mg, 400 mg, 600 mg and 800 mg (for SPH Shanghai Zhongxi Pharmaceutical Co. Ltd).

Pharmula Laboratories signed agreement

Pharmula Laboratories signed agreement with SPH Shanghai Zhongxi Pharmaceutical Co. Ltd., on development, FDA registration, and US marketing of generic Eslicarbazspine tablets.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt